Teal Omics is a biotech startup striving to revolutionize the field of aging research and the fight against age-related diseases. Founded in 2021, Teal Omics has positioned itself as a pioneer in developing innovative aging biomarkers to offer profound biological insights. The company's slogan, "Teal develops novel aging biomarkers to provide powerful biological insights," reflects its commitment to pushing the boundaries of traditional aging research. With a focus on Biopharma, Biotechnology, Health and Wellness, and Life Sciences, Teal Omics operates at the intersection of health and technology, catering to an ever-growing market that prioritizes longevity and well-being. While details about its headquarters and last investment remain unreported, Teal Omics stands as a promising player in the biotech landscape, offering potential opportunities for venture capital investors seeking to tap into the burgeoning field of anti-aging technologies.
General Information
BounceWatch is an independent company data service, not affiliated with Teal Omics. To contact Teal Omics, visit tealomics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biopharma
About Teal Omics
Taxonomy: Aging biomarkers, Healthcare transformation, Proteomics, Human genetics, Disease monitoring, Target discovery
No funding data available for Teal Omics yet.
Teal Omics Alternatives & Competitors
We are harnessing the biology of human aging to develop novel targets and therapies for metabolic di...
Cajal Therapeutics is a Seattle biotechnology company dedicated to developing innovative medicines f...
Transforming health, healthcare and drug discovery and development through the power of genomics
FAQ About Teal Omics
Source: BounceWatch company record for Teal Omics, https://bouncewatch.com/company/teal-omics, updated 8 January 2025. When citing, please name BounceWatch and link this page.